|
Rapamycin (sirolimus) Clinical Trials
1 actively recruiting trial across 1 location
Also known as: Rapamune
Pipeline
Phase 1/2: 1
Top Sponsors
- Umoja Biopharma1
Indications
- Primary Mediastinal B-cell Lymphoma1
- Richter Transformation Lymphoma1
- Lymphoma, B-Cell1
- Grade 3b Follicular Lymphoma1
- High-grade B-cell Lymphoma1
Nashville, Tennessee1 trial
A Phase 1/2 Study of UB-VV400 With Rapamycin in Relapsed/Refractory B-cell Malignancies
Sarah Cannon Research Institute
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.